dexa-synto elixir 0.5mg/5ml oral solution
codal-synto limited (0000010484) 21 constantinoupoleos str., limassol, 3011, 51785 (3508) - dexamethasone - oral solution - 0.5mg/5ml - dexamethasone (0000050022) 0,01g - dexamethasone
cataflam 50mg tablet, coated
novartis ireland limited (0000010772) vista building, elm park, merrion road, ballsbridge, dublin, dublin 4 - diclofenac potassium - tablet, coated - 50mg - diclofenac potassium (8000001048) 50mg - diclofenac
seretide evohaler 25mcg/50mcg pressurised inhalation, suspension
glaxosmithkline (ireland) limited (0000010774) 12 riverwalk, citywest business campus, dublin, dublin 24 - salmeterol xinafoate; fluticasone propionate - pressurised inhalation, suspension - 25mcg/50mcg - salmeterol xinafoate (8000001995) 25ug; fluticasone propionate (8000031552) 50mcg - salmeterol and other anti-asthmatics
flixotide nebules 0.5mg/2ml inhalation
glaxosmithkline (ireland) limited (0000010774) 12 riverwalk, citywest business campus, dublin, dublin 24 - fluticasone propionate - inhalation - 0.5mg/2ml - fluticasone propionate (8000031552) 0,5mg - fluticasone
trileptal 60mg/ml oral suspension
novartis ireland limited (0000010772) vista building, elm park, merrion road, ballsbridge, dublin, dublin 4 - oxcarbazepine - oral suspension - 60mg/ml - oxcarbazepine (0028721075) 60mg - oxcarbazepine
zovirax 200mg/5ml oral suspension
glaxosmithkline trading services limited. (0000010863) 12 riverwalk, citywest business campus, dublin, dublin 24 - aciclovir - oral suspension - 200mg/5ml - aciclovir (0059277893) 200mg - aciclovir
sutent
pfizer limited - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - Αντινεοπλασματικοί παράγοντες - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults. experience with sutent as first-line treatment is limited (see section 5.
dapagliflozin viatris
viatris limited - dapagliflozin - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - Φάρμακα που χρησιμοποιούνται στον διαβήτη - type 2 diabetes mellitusdapagliflozin viatris is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance. - in addition to other medicinal products for the treatment of type 2 diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 και 5. heart failuredapagliflozin viatris is indicated in adults for the treatment of symptomatic chronic heart failure with reduced ejection fraction. chronic kidney diseasedapagliflozin viatris is indicated in adults for the treatment of chronic kidney disease.
lextemy
mylan ire healthcare limited - bevacizumab - colorectal neoplasms; breast neoplasms; ovarian neoplasms; fallopian tube neoplasms; peritoneal neoplasms; carcinoma, non-small-cell lung; carcinoma, renal cell; uterine cervical neoplasms - Αντινεοπλασματικοί παράγοντες - treatment of carcinoma of the colon or rectum, breast cancer, non-small cell lung cancer, renal cell cancer, epithelial ovarian, fallopian tube or primary peritoneal cancer, and carcinoma of the cervix.
fexeric
akebia europe limited - συμπλέγματος συντονισμού κιτρικού σιδήρου - hyperphosphatemia; renal dialysis - Φάρμακα για τη θεραπεία της υπερκαλιαιμίας και της υπερφωσφαταιμίας - Το fexeric ενδείκνυται για τον έλεγχο της υπερφωσφαταιμίας σε ενήλικες ασθενείς με χρόνια νεφρική νόσο (ckd).